ATXI Annual Cash & Cash Equivalents
$1.78 M
-$4.92 M-73.42%
31 December 2023
Summary:
As of January 23, 2025, ATXI annual cash & cash equivalents is $1.78 million, with the most recent change of -$4.92 million (-73.42%) on December 31, 2023. During the last 3 years, it has fallen by -$1.35 million (-43.07%). ATXI annual cash & cash equivalents is now -84.87% below its all-time high of $11.78 million, reached on December 31, 2017.ATXI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXI Quarterly Cash And Cash Equivalents
$2.60 M
-$2.32 M-47.20%
30 September 2024
Summary:
As of January 23, 2025, ATXI quarterly cash and cash equivalents is $2.60 million, with the most recent change of -$2.32 million (-47.20%) on September 30, 2024. Over the past year, it has increased by +$814.00 thousand (+45.65%). ATXI quarterly cash and cash equivalents is now -92.51% below its all-time high of $34.68 million, reached on June 30, 2017.ATXI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.4% | +45.6% |
| 3 y3 years | -43.1% | -31.0% |
| 5 y5 years | -33.3% | -70.3% |
ATXI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.4% | at low | -68.5% | +1513.0% |
| 5 y | 5-year | -79.6% | at low | -70.3% | +1513.0% |
| alltime | all time | -84.9% | >+9999.0% | -92.5% |
Avenue Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.60 M(-47.2%) |
| June 2024 | - | $4.92 M(+54.0%) |
| Mar 2024 | - | $3.19 M(+79.1%) |
| Dec 2023 | $1.78 M(-73.4%) | $1.78 M(+1007.5%) |
| Sept 2023 | - | $161.00 K(-89.8%) |
| June 2023 | - | $1.57 M(-80.9%) |
| Mar 2023 | - | $8.24 M(+22.8%) |
| Dec 2022 | $6.71 M(+78.3%) | $6.71 M(+2991.2%) |
| Sept 2022 | - | $217.00 K(-75.6%) |
| June 2022 | - | $890.00 K(-51.4%) |
| Mar 2022 | - | $1.83 M(-51.3%) |
| Dec 2021 | $3.76 M(+20.1%) | $3.76 M(+543.2%) |
| Sept 2021 | - | $585.00 K(-47.8%) |
| June 2021 | - | $1.12 M(-38.6%) |
| Mar 2021 | - | $1.82 M(-41.7%) |
| Dec 2020 | $3.13 M | $3.13 M(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $4.33 M(-17.7%) |
| June 2020 | - | $5.26 M(-20.0%) |
| Mar 2020 | - | $6.57 M(-24.8%) |
| Dec 2019 | $8.74 M(+227.4%) | $8.74 M(+0.0%) |
| Sept 2019 | - | $8.74 M(-16.4%) |
| June 2019 | - | $10.46 M(-64.5%) |
| Mar 2019 | - | $29.45 M(+1002.5%) |
| Dec 2018 | $2.67 M(-77.3%) | $2.67 M(-44.4%) |
| Sept 2018 | - | $4.80 M(-46.3%) |
| June 2018 | - | $8.94 M(-40.3%) |
| Mar 2018 | - | $14.96 M(+27.0%) |
| Dec 2017 | $11.78 M(+5880.7%) | $11.78 M(-26.6%) |
| Sept 2017 | - | $16.05 M(-53.7%) |
| June 2017 | - | $34.68 M(>+9900.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $197.00 K(+1307.1%) | $197.00 K |
| Dec 2015 | $14.00 K | - |
FAQ
- What is Avenue Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Avenue Therapeutics?
- What is Avenue Therapeutics annual cash & cash equivalents year-on-year change?
- What is Avenue Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Avenue Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ATXI is $1.78 M
What is the all time high annual cash & cash equivalents for Avenue Therapeutics?
Avenue Therapeutics all-time high annual cash & cash equivalents is $11.78 M
What is Avenue Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ATXI annual cash & cash equivalents has changed by -$4.92 M (-73.42%)
What is Avenue Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ATXI is $2.60 M
What is the all time high quarterly cash and cash equivalents for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly cash and cash equivalents is $34.68 M
What is Avenue Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ATXI quarterly cash and cash equivalents has changed by +$814.00 K (+45.65%)